Skip to main content
    E

    Elevance Health Inc (ELV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $446.42
    +16.73 (+3.89%)

    Market Cap: $92.84B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Elevance Health Inc (ELV) Financials: Revenue, Profit and Cash Flow

    Updated Oct 21, 2026. Financial statements from company filings, amounts in US dollars.

    Elevance Health reported revenue of $199.13B for the fiscal year ended Dec 31, 2025, up 12.6% from the year before. That year, net income was $5.66B with a net margin of 2.8%, operating cash flow was $4.29B and free cash flow was $3.17B. The quarter ended Sep 30, 2026 had revenue of $51.43B and net income of $1.34B.

    Revenue and Margins

    The operating margin was 4.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $84.86B, a compound annual rate of 9.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$199.13B+12.6%14.9%4.1%2.8%
    Dec 2024$176.81B+3.2%5.4%5.0%3.4%
    Dec 2023$171.34B+9.4%17.3%5.1%3.5%
    Dec 2022$156.59B+13.0%17.2%5.4%3.8%
    Dec 2021$138.64B+13.8%18.2%6.3%4.4%
    Dec 2020$121.87B+16.9%20.4%5.8%3.8%
    Dec 2019$104.21B+13.1%19.6%6.5%4.6%
    Dec 2018$92.11B+2.3%21.9%6.3%4.1%
    Dec 2017$90.04B+6.1%19.8%5.5%4.3%
    Dec 2016$84.86BN/A21.2%6.2%2.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 5.2% from the year before. In the quarter ended Sep 2026, net income rose 12.6% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$199.13B$176.81B$171.34B$156.59B$138.64B$121.87B$104.21B$92.11B$90.04B$84.86B
    Cost of revenue$169.40B$167.34B$141.62B$129.68B$113.47B$97.00B$83.78B$71.89B$72.24B$66.83B
    Gross profit$29.72B$9.47B$29.72B$26.92B$25.17B$24.87B$20.43B$20.21B$17.80B$18.03B
    Operating income$8.11B$8.89B$8.74B$8.45B$8.79B$7.06B$6.73B$5.83B$4.99B$5.28B
    Net income$5.66B$5.97B$5.99B$5.89B$6.15B$4.57B$4.81B$3.75B$3.84B$2.47B
    EBITDA$9.66B$10.48B$10.49B$10.13B$10.10B$8.21B$7.87B$6.96B$5.88B$6.19B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$51.43B$50.47B$50.18B$49.75B$50.71B$49.78B$48.89B$45.44B$45.15B$43.65B$42.58B$42.65B
    Gross profit$8.01B$7.96B$9.10B$6.16B$7.19B$7.78B$8.60B-$8.83B$1.83B$8.25B$8.21B$11.29B
    Operating income$2.15B$2.30B$2.66B$581.00M$1.76B$2.63B$3.14B$946.00M$1.71B$3.03B$3.20B$1.26B
    Net income$1.34B$1.45B$1.76B$546.00M$1.19B$1.74B$2.18B$413.00M$1.01B$2.30B$2.25B$831.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $32.05B exceeded cash and equivalents by $22.55B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$121.49B$116.89B$108.93B$102.75B$97.46B$86.61B$77.45B$71.57B$70.54B$65.08B
    Current assets$63.00B$58.94B$60.03B$55.62B$51.12B$45.75B$39.03B$34.32B$36.26B$34.31B
    Cash and equivalents$9.49B$8.29B$6.53B$7.39B$4.88B$5.74B$4.94B$3.93B$3.61B$4.08B
    Total liabilities$77.47B$75.46B$69.52B$66.42B$61.29B$53.42B$45.73B$43.03B$44.04B$39.98B
    Short-term debt$1.25B$2.01B$1.87B$1.76B$1.87B$700.00M$2.30B$1.99B$2.55B$1.37B
    Long-term debt$30.80B$29.22B$23.25B$22.35B$21.16B$19.34B$17.79B$17.22B$17.38B$14.36B
    Shareholder equity$43.88B$41.31B$39.31B$36.24B$36.09B$33.20B$31.73B$28.54B$26.50B$25.10B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$127.80B$126.44B$125.83B$121.49B$122.75B$121.94B$119.72B$116.89B$116.53B$112.99B$111.89B$108.93B
    Total liabilities$83.01B$81.42B$81.78B$77.47B$78.67B$78.09B$77.10B$75.46B$72.65B$70.69B$71.18B$69.52B
    Cash and equivalents$10.35B$10.23B$9.66B$9.49B$8.71B$8.56B$7.50B$8.29B$7.87B$6.50B$6.23B$6.53B
    Shareholder equity$44.68B$44.88B$43.90B$43.88B$43.95B$43.72B$42.50B$41.31B$43.77B$42.19B$40.61B$39.31B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 73.9% of operating cash flow. Dividends and share repurchases together came to 130.3% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$4.29B$5.81B$8.06B$8.40B$8.36B$10.69B$6.06B$3.83B$4.18B$3.27B
    Capital expenditures$1.12B$1.26B$1.30B$1.15B$1.09B$1.02B$1.08B$1.21B$791.00M$584.00M
    Free cash flow$3.17B$4.55B$6.76B$7.25B$7.28B$9.67B$4.98B$2.62B$3.39B$2.69B
    Dividends paid$1.53B$1.51B$1.40B$1.23B$1.10B$954.00M$818.00M$776.00M$705.00M$684.00M
    Share repurchases$2.60B$2.90B$2.68B$2.32B$1.90B$2.70B$1.70B$1.69B$2.00B$0
    Investing cash flow-$1.34B-$5.17B-$5.57B-$4.56B-$9.64B-$7.32B-$2.79B-$1.26B-$5.08B-$514.00M
    Financing cash flow-$1.74B$1.19B-$3.35B-$1.32B$423.00M-$2.57B-$2.27B-$2.24B$427.00M-$799.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$1.27B$1.91B$4.33B$84.00M$1.14B$2.05B$1.02B$706.00M$2.68B$447.00M$1.98B-$2.97B
    Capital expenditures$267.00M$287.00M$235.00M$293.00M$360.00M$267.00M$196.00M$322.00M$332.00M$323.00M$279.00M$326.00M
    Free cash flow$1.00B$1.63B$4.10B-$209.00M$775.00M$1.79B$821.00M$384.00M$2.35B$124.00M$1.70B-$3.30B
    Last 12 quarters

    Frequently Asked Questions About ELV

    What is Elevance Health's annual revenue?

    Elevance Health reported revenue of $199.13B for the fiscal year ended Dec 31, 2025.

    How fast is Elevance Health's revenue growing?

    Revenue was up 12.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 8.3%.

    Is Elevance Health profitable?

    Yes. Elevance Health reported net income of $5.66B for the fiscal year ended Dec 31, 2025, with a net margin of 2.8%.

    How much free cash flow does ELV generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $4.29B minus capital expenditures of $1.12B produced free cash flow of $3.17B.

    How much debt does Elevance Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $30.80B, short-term debt of $1.25B and cash and equivalents of $9.49B.